ReFissa's Unit Acquisition

ReFissa raised a round of funding on February 02, 2017. Investors include ZO Skin Health.

ReFissa 0.05% is a prescription medicine, developed by Suneva Medical, that may reduce fine facial wrinkles and mottled hyperpigmentation in patients who also protect their skin from the sun and wear …

Articles about ReFissa's Unit Acquisition: